TY - JOUR
T1 - Proactive and systematic multidimensional needs assessment in patients with advanced cancer approaching palliative care :
T2 - a study protocol
AU - Pergolizzi, Denise
AU - Crespo, Iris
AU - Balaguer Santamaría, Albert
AU - Monforte-Royo, Cristina
AU - Alonso-Babarro, Alberto
AU - Arantzamendi, Maria
AU - Belar, Alazne
AU - Centeno, Carlos
AU - Goni-Fuste, Blanca
AU - Julià-Torras, Joaquim
AU - Martinez, Marina
AU - Mateo-Ortega, Dolors
AU - May, Luis
AU - Moreno-Alonso, Deborah
AU - Nabal Vicuña, Maria
AU - Noguera, Antonio
AU - Pascual López, Antonio
AU - Perez-Bret, Encarnacion
AU - Rocafort, Javier
AU - Rodríguez-Prat, Andrea
AU - Rodriguez, Dulce
AU - Sala, Carme
AU - Serna, Judith
AU - Porta-Sales, Josep
PY - 2020
Y1 - 2020
N2 - The benefits of palliative care rely on how healthcare professionals assess patients' needs in the initial encounter/s; crucial to the design of a personalised therapeutic plan. However, there is currently no evidence-based guideline to perform this needs assessment. We aim to design and evaluate a proactive and systematic method for the needs assessment using quality guidelines for developing complex interventions. This will involve patients, their relatives and healthcare professionals in all phases of the study and its communication to offer clinical practice a reliable approach to address the palliative needs of patients. To design and assess the feasibility of an evidence-based, proactive and systematic Multidimensional needs Assessment in Palliative care (MAP) as a semistructured clinical interview guide for initial palliative care encounter/s in patients with advanced cancer. This is a two-phase multisite project conducted over 36 months between May 2019 and May 2022. Phase I includes a systematic review, discussions with stakeholders and Delphi consensus. The evidence gathered from phase I will be the basis for the initial versions of the MAP, then submitted to Delphi consensus to develop a preliminary guide of the MAP for the training of clinicians in the feasibility phase. Phase II is a mixed-methods multicenter feasibility study that will assess the MAP's acceptability, participation, practicality, adaptation and implementation. A nested qualitative study will purposively sample a subset of participants to add preliminary clues about the benefits and barriers of the MAP. The evidence gathered from phase II will build a MAP user guide and educational programme for use in clinical practice. Ethical approval for this study has been granted by the university research ethics committee where the study will be carried out (approval reference MED-2018-10). Dissemination will be informed by the results obtained and communication will occur throughout.
AB - The benefits of palliative care rely on how healthcare professionals assess patients' needs in the initial encounter/s; crucial to the design of a personalised therapeutic plan. However, there is currently no evidence-based guideline to perform this needs assessment. We aim to design and evaluate a proactive and systematic method for the needs assessment using quality guidelines for developing complex interventions. This will involve patients, their relatives and healthcare professionals in all phases of the study and its communication to offer clinical practice a reliable approach to address the palliative needs of patients. To design and assess the feasibility of an evidence-based, proactive and systematic Multidimensional needs Assessment in Palliative care (MAP) as a semistructured clinical interview guide for initial palliative care encounter/s in patients with advanced cancer. This is a two-phase multisite project conducted over 36 months between May 2019 and May 2022. Phase I includes a systematic review, discussions with stakeholders and Delphi consensus. The evidence gathered from phase I will be the basis for the initial versions of the MAP, then submitted to Delphi consensus to develop a preliminary guide of the MAP for the training of clinicians in the feasibility phase. Phase II is a mixed-methods multicenter feasibility study that will assess the MAP's acceptability, participation, practicality, adaptation and implementation. A nested qualitative study will purposively sample a subset of participants to add preliminary clues about the benefits and barriers of the MAP. The evidence gathered from phase II will build a MAP user guide and educational programme for use in clinical practice. Ethical approval for this study has been granted by the university research ethics committee where the study will be carried out (approval reference MED-2018-10). Dissemination will be informed by the results obtained and communication will occur throughout.
KW - Cancer
KW - Advanced cancer
KW - Adult palliative care
KW - Palliative medicine
KW - Multidimensional needs assessment
KW - Comprehensive assessment
UR - https://www.scopus.com/pages/publications/85079067830
U2 - 10.1136/bmjopen-2019-034413
DO - 10.1136/bmjopen-2019-034413
M3 - Article
C2 - 32024792
SN - 2044-6055
VL - 10
JO - BMJ Open
JF - BMJ Open
ER -